Reproductive · Gynecology
The facts most likely to be tested
Persistent infection with high-risk Human Papillomavirus (HPV) types 16 and 18 is the primary etiologic agent for cervical intraepithelial neoplasia (CIN).
The transformation zone of the cervix is the site of highest risk for squamous metaplasia and subsequent dysplastic changes.
Atypical Squamous Cells of Undetermined Significance (ASC-US) in patients aged 25-29 requires reflex HPV testing to determine the need for colposcopy.
High-grade squamous intraepithelial lesion (HSIL) on cytology or biopsy necessitates immediate colposcopy regardless of age.
Colposcopy with directed biopsy is the gold standard diagnostic procedure for evaluating abnormal cervical screening results.
Loop Electrosurgical Excision Procedure (LEEP) or cold knife conization is indicated for histologically confirmed CIN 2 or 3 to prevent progression to invasive carcinoma.
Current guidelines recommend primary HPV testing as the preferred screening method for cervical cancer starting at age 25.
Vignette unlocked
A 28-year-old G1P1 woman presents for a routine follow-up after a recent Pap smear. Her cytology results return as Atypical Squamous Cells of Undetermined Significance (ASC-US). She has no history of abnormal cervical screenings and is currently using oral contraceptives. Her HPV co-testing is positive for high-risk HPV genotypes. She has no complaints of postcoital bleeding or pelvic pain.
What is the most appropriate next step in the management of this patient?
Colposcopy
According to ASCCP guidelines, patients aged 25-29 with ASC-US and positive high-risk HPV testing require colposcopy to rule out underlying high-grade dysplasia.
Full handout
High yield triage
Etiology / Epidemiology
Driven by HPV 16 and 18; primary risk factors include early sexual debut, multiple partners, and smoking.
Clinical Manifestations
Usually asymptomatic; postcoital bleeding or intermenstrual bleeding are the most common clinical red flags.
Diagnosis
Colposcopy with biopsy is the gold standard; ASC-US or higher on cytology triggers reflex testing.
Treatment
CIN 1 is managed with observation; CIN 2/3 requires LEEP or conization.
Prognosis
Most CIN 1 regresses; 100% of invasive cervical cancers are preceded by persistent high-risk HPV.
Full handout
Epidemiology & Etiology
Cervical intraepithelial neoplasia (CIN) is caused by persistent infection with high-risk HPV types, primarily 16 and 18. Major risk factors include early onset of sexual activity, immunocompromise (e.g., HIV), and long-term oral contraceptive use.
Pertinent Anatomy
The transformation zone is the site of active squamous metaplasia and the primary location for dysplastic changes. This area is most vulnerable to HPV integration during adolescence and early adulthood.
Pathophysiology
HPV E6 and E7 proteins inhibit tumor suppressor genes p53 and Rb, respectively. This leads to uncontrolled cellular proliferation and genomic instability. Persistent infection allows for the progression from low-grade (CIN 1) to high-grade (CIN 2/3) lesions.
Clinical Manifestations
Patients are typically asymptomatic, making screening essential. When symptomatic, patients present with postcoital bleeding or foul-smelling discharge. Unexplained weight loss or pelvic pain may indicate progression to invasive carcinoma.
Diagnosis
Screening begins with Pap smear cytology. Abnormal results require HPV DNA testing and, if indicated, colposcopy with biopsy. Acetic acid application during colposcopy reveals acetowhite changes, which guide the biopsy site.
Treatment
CIN 1 is managed with repeat cytology/HPV testing at 12 months. CIN 2/3 requires excisional procedures like LEEP or cold knife conization. Pregnancy requires careful management, as excisional procedures increase the risk of cervical insufficiency.
Prognosis
CIN 1 has a high rate of spontaneous regression. CIN 2/3 carries a significant risk of progression to invasive squamous cell carcinoma if left untreated. Patients require long-term surveillance with co-testing for at least 20 years.
Differential Diagnosis
Cervical polyps: benign, fleshy growths often causing spotting
Cervicitis: usually associated with Chlamydia/Gonorrhea and purulent discharge
Cervical cancer: presents with friable, ulcerated mass on exam
Vaginal atrophy: common in postmenopausal women with pale, thin mucosa
Condyloma acuminata: HPV-related genital warts, usually low-risk types